The R&D blueprint operates through a series of well-defined steps:
Risk Assessment: Evaluating the potential impact of emerging health threats. Research Prioritization: Identifying key research questions and target areas for intervention. Rapid Funding: Allocating funds swiftly to support high-priority research projects. Clinical Trials: Conducting accelerated clinical trials to test the efficacy and safety of new interventions. Regulatory Approval: Navigating regulatory pathways to obtain emergency use authorizations or full approvals for new products. Implementation: Deploying effective interventions to control and mitigate the outbreak.
